Sign in
CompletedPhase 2

BOOSTCAMP: Boosting the endocannabinoid system before the treatment of anxiety symptoms

Key facts

Who runs it
Universitair Medisch Centrum Utrecht
Where
Netherlands1 site in 1 countryChoose a country to see its sites
Status
Completed
Phase
Phase 2
People taking part
82 people enrolled
Started
29 Oct 2024
Ended
1 Oct 2026
Type of study
Interventional
Record updated
29 October 2024

Who can take part

Age
18 years to 64 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 12 criteriaShow less

Who can take part

  • Dutch uniformed personnel, which are (former) police-officers, firefighters, ambulance paramedics, military personnel or veterans
  • Age between 18-65
  • Waiting for therapy for the treatment of a trauma and stressor-related and/or an anxiety disorder (as determined by the MINI PLUS psychiatric interview)

Who cannot take part

  • Alcohol and/or drug dependence
  • Severe co-morbidity (severe major depressive or bipolar disorder and/or psychosis)
  • (a history of) epilepsy or brain damage, cardiac, renal or liver abnormalities
  • (a history of) allergies to medication (adverse reactions or rash)
  • Individuals taking certain medications known to have potential interactions with CBD (i.e., steroids, HMG-CoA reductase inhibitors, calcium channel blockers, antihistamines, antivirals, immune modulators, benzodiazepines, anti-arrhythmic, antibiotics, anesthetics, antipsychotics, antidepressants, anti-epileptics, beta blockers, proton pump inhibitors, NSAIDs, angiotensin II blockers, oral hypoglycemic agents, and sulfonylureas)
  • Individuals that had been diagnosed with intestinal, liver, or renal diseases that would affect absorption or clearance of CBD
  • Inability to adequately read or speak Dutch
  • Used cannabis, synthetic cannabinoid, cannabinoid analogue, or any CBD or THC-containing product within 30 days of eligibility screening
  • For women: pregnant, a wish to become pregnant, or nursing

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

to examine the effects of a 2-week administration of Cannabidiol (CBD) in alleviating anxiety symptoms before anxiety or PTSD treatments in Dutch uniformed personnel

Saves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.

Data and sources

Registry record
Listed on the EU's official list of trials (CTIS).How to verify a trial in the registry
Official title
BOOSTCAMP - Boosting the endocannabinoid system before the treatment of anxiety symptoms
Record updated
29 October 2024